Abbott Laboratories (ABT) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI

Abbott Laboratories (ABT) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI | MarketCI

ABT

Market Closed

Abbott Laboratories

NYSEHealthcare Medical - Devices

114.00K employees

CEO: Robert Ford

Founded: 1980

$88.38

+$0.00(+NaN%)

Market Cap

153.94B

Beta

0.62

52W Range

N/A

Dividend Yield

2.76%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Financial Statements

Comprehensive breakdown of financial statements and performance metrics

Gross Margin

55.5%

15.4%

CAGR: 1.5%

Profit after direct costs

Operating Margin

18.2%

17.9%

CAGR: -3.3%

Core business profitability

Net Margin

14.7%

-51.3%

CAGR: -2.0%

Bottom line profitability

Revenue Growth

5.7%

YoY

CAGR: 0.7%

Top line growth rate

Revenue Flow Analysis

Visual flow showing how ABT allocates revenue across expenses and profit

Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin

55.5%

$24.61B

Operating Margin

18.2%

$8.05B

Net Margin

14.7%

$6.52B

Detailed Income Statement

Complete profit and loss breakdown with margin analysis and historical comparison

Item	2021	2022	2023	2024	2025	YoY Change
Total Revenue	43.08B	43.65B	40.11B	41.95B	44.33B	5.7%
Cost of Revenue	(19.86B)	(21.33B)	(20.07B)	(20.63B)	(19.72B)	-4.4%
Gross Profit	23.21B	22.32B	20.04B	21.32B	24.61B	15.4%
Operating Expenses
Research & Development	(2.74B)	(2.85B)	(2.72B)	(2.82B)	(2.96B)	4.7%
Selling, General & Administrative	(11.28B)	(11.11B)	(10.88B)	(11.65B)	(12.38B)	6.2%
General & Administrative	—	—	—	—	(12.38B)	—
Depreciation & Amortization	(3.54B)	(3.27B)	(3.24B)	(3.22B)	(2.75B)	-14.7%
Operating Income (EBIT)	9.20B	8.36B	6.43B	6.83B	8.05B	17.9%
Non-Operating Items
Interest Income	43.00M	183.00M	385.00M	344.00M	230.00M	-33.1%
Interest Expense	(410.00M)	(315.00M)	(698.00M)	(603.00M)	(341.00M)	-43.4%
Other Income/Expenses (Net)	-989.00M	-56.00M	229.00M	188.00M	418.00M	122.3%
Income Before Tax	8.21B	8.31B	6.66B	7.01B	8.47B	20.7%
Income Tax Expense	(1.14B)	(1.37B)	(941.00M)	(6.39B)	(1.94B)	-130.4%
Net Income	7.07B	6.93B	5.72B	13.40B	6.52B	-51.3%
Per Share Metrics
Earnings Per Share (Basic)	$4	$4	$3	$8	$4	-51.2%
Weighted Avg Shares Outstanding	1.77B	1.75B	1.73B	1.73B	1.75B	0.9%
Weighted Avg Shares Outstanding (Diluted)	1.79B	1.76B	1.75B	1.75B	1.75B	-0.1%
EBITDA	12.16B	11.89B	10.61B	10.83B	11.55B	6.6%

Explore ABT

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

ABT in the Healthcare

Large Cap

Healthcare

Browse sector stocks →

Medical - Devices

Browse industry stocks →